Wild Prose can't read and can't do mathInteresting, not only can you not add -- 11+15 does not equal 6 cents.
You can also NOT read. In my post about the analyst, I did state at the
end of my post "A target stock price range is inestimable given the early
stage of Advectus’ project"
WILD PROSE -- You obviously suffer from a severe case of "Selectivevism".
Selective reading, selective math, selective posting. As long as it is
negative, then you post it. Personally from my standpoint I think you
suffer from a severe case of "selective verbal diarrhea"
MY POST RE-POSTED:
________________________________________________________
THE ANALYST'S REPORT STATES THE FOLLOWING:
- f/d approx. 53 million shares, insiders control at least 20% f/d shares
(I WOULD THINK HE IS INCLUDING OUTSTANDING WARRANTS)
- all amounts in USD unless otherwise indicated
- Based on the research and analysis below, it is my opinion that
Advectus’ Nanocure™ project for malignant brain cancer therapy
using nanotechnology has an estimated present value of $388 million,
based on US market demand only and terminal sales in 2018
(THIS MEANS THE PRESENT DAY VALUE OF AVX IS $388 MILLION
AND THAT HE EXPECTS SALES OF NANOCURE TO END IN 2018 --
WILD PROSE OBVIOUSLY IS VERY DENSE AND DOES NOT UNDERSTAND
THIS STATEMENT)
THEN THE ANALYST GOES ON TO SAY....
- At current stock price levels, AVX stock should be considered as a
reasonable, speculative buy for investors interested in high-risk
investments
- A target stock price range is inestimable given the early stage of
Advectus’ project